Sacramento, CALIFORNIA3 Active Studies

Primary Biliary Cholangitis Clinical Trials in Sacramento, CALIFORNIA

Find 3 actively recruiting primary biliary cholangitis clinical trials in Sacramento, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
744
Enrolling

Recruiting Primary Biliary Cholangitis Studies in Sacramento

About Primary Biliary Cholangitis Clinical Trials in Sacramento

Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.

There are currently 3 primary biliary cholangitis clinical trials recruiting participants in Sacramento, CALIFORNIA. These studies are seeking a combined 744 participants. Research is being sponsored by Gilead Sciences, Ipsen, Zydus Therapeutics Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Primary Biliary Cholangitis Clinical Trials in Sacramento — FAQ

Are there primary biliary cholangitis clinical trials in Sacramento?

Yes, there are 3 primary biliary cholangitis clinical trials currently recruiting in Sacramento, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What primary biliary cholangitis treatments are being tested?

The 3 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.

Data updated March 2, 2026 from ClinicalTrials.gov